Wolverine Asset Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-13,700
Closed -$136K 1714
2025
Q3
$136K Buy
13,700
+8,500
+163% +$88.5K ﹤0.01% 1066
2025
Q2
$51.6K Buy
+5,200
New +$54.8K ﹤0.01% 1211
2023
Q1
Sell
-1,000
Closed -$10.6K 1938
2022
Q4
$10.6K Hold
1,000
﹤0.01% 1616
2022
Q3
$10K Sell
1,000
-200
-17% -$2.61K ﹤0.01% 1974
2022
Q2
$15K Hold
1,200
﹤0.01% 1893
2022
Q1
$13K Sell
1,200
-500
-29% -$6.07K ﹤0.01% 1842
2021
Q4
$23K Hold
1,700
﹤0.01% 1683
2021
Q3
$32K Buy
+1,700
New +$22.6K ﹤0.01% 1522

Other funds holding DVAX

Wolverine Asset Management's DVAX Position: Q1 2023 in Review

Wolverine Asset Management sold out of Dynavax Technologies (DVAX) in Q1 2023, closing a stake of 149 shares — an estimated $1.58K sold.

Wolverine Asset Management first reported a position in DVAX in Q2 2013 and held it in 5 quarters. The position peaked at $9K in Q2 2013. 216 funds tracked by Wall St. Rank hold DVAX as of Q1 2023.

  • Wolverine Asset Management reported no remaining Dynavax Technologies position as of Q1 2023 after selling out during the quarter.
  • Wolverine Asset Management sold 149 Dynavax Technologies shares in Q1 2023, an estimated $1.58K.
  • Wolverine Asset Management first reported a position in Dynavax Technologies in Q2 2013 and held it in 5 quarters.
  • Wolverine Asset Management's Dynavax Technologies position peaked at $9K in Q2 2013.
  • 216 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2023.

Based on Wolverine Asset Management's 13F filing for Q1 2023, filed 8 May 2023.